Physiol Rev 56(4):778826 Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D et al (2008) DrugBank: a knowledgebase for drugs, drug actions and drug targets
Patients with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, severe gastroparesis, active pancreatitis, or who are pregnant or planning pregnancy are generally not candidates for GLP-1 therapy
Safety Considerations and Who Should Discuss GHK-Cu with a Provider GHK-Cu is not FDA-approved for any indication, and safety data in humans is minimal
Ozempic contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist
Use your valid EU prescription at any pharmacy across the European Union
The practice is legal under the Federal Food, Drug and Cosmetic Act in certain circumstances